Armando Lira

431 total citations
7 papers, 334 citations indexed

About

Armando Lira is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Economics and Econometrics. According to data from OpenAlex, Armando Lira has authored 7 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Economics and Econometrics. Recurrent topics in Armando Lira's work include Lipoproteins and Cardiovascular Health (4 papers), Pharmaceutical Economics and Policy (3 papers) and Cardiac and Coronary Surgery Techniques (3 papers). Armando Lira is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Pharmaceutical Economics and Policy (3 papers) and Cardiac and Coronary Surgery Techniques (3 papers). Armando Lira collaborates with scholars based in United States, Switzerland and Italy. Armando Lira's co-authors include Frederick J. Raal, Ransi Somaratne, Allen Xue, Robert P. Giugliano, Michael J. Koren, Robert C. Scott, Evan A. Stein, Marc S. Sabatine, Simon Jackson and Dirk Blom and has published in prestigious journals such as JAMA, Journal of Lipid Research and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

Armando Lira

7 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Armando Lira United States	6	267	94	84	67	49	7	334
Andrew Friedman United States	6	275 1.0×	93 1.0×	83 1.0×	39 0.6×	70 1.4×	8	382
Julia Brandts Germany	11	211 0.8×	56 0.6×	82 1.0×	52 0.8×	82 1.7×	30	333
Yong-Un Kim United States	6	328 1.2×	94 1.0×	104 1.2×	51 0.8×	87 1.8×	7	370
Yong‐Joon Lee South Korea	10	357 1.3×	118 1.3×	154 1.8×	58 0.9×	92 1.9×	43	464
Stephen A. LaHaye Canada	8	201 0.8×	58 0.6×	91 1.1×	38 0.6×	41 0.8×	13	308
Julius L. Katzmann Germany	11	220 0.8×	69 0.7×	86 1.0×	48 0.7×	74 1.5×	31	345
Arjen J. Cupido Netherlands	10	242 0.9×	54 0.6×	129 1.5×	63 0.9×	100 2.0×	14	428
Rutger Verbeek Netherlands	9	341 1.3×	51 0.5×	164 2.0×	83 1.2×	137 2.8×	16	421
B P Kimball Canada	5	359 1.3×	56 0.6×	155 1.8×	60 0.9×	101 2.1×	9	440
Faisal Majeed United States	4	172 0.6×	45 0.5×	62 0.7×	45 0.7×	86 1.8×	7	281

Countries citing papers authored by Armando Lira

Since Specialization

Citations

This map shows the geographic impact of Armando Lira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armando Lira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armando Lira more than expected).

Fields of papers citing papers by Armando Lira

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armando Lira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armando Lira. The network helps show where Armando Lira may publish in the future.

Co-authorship network of co-authors of Armando Lira

This figure shows the co-authorship network connecting the top 25 collaborators of Armando Lira. A scholar is included among the top collaborators of Armando Lira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armando Lira. Armando Lira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Wiggins, Barbara S., et al.. (2018). Evolocumab: Considerations for the Management of Hyperlipidemia. Current Atherosclerosis Reports. 20(4). 17–17. 11 indexed citations

2.

Hovingh, G. Kees, Frederick J. Raal, Ricardo Dent, et al.. (2017). Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia. Journal of clinical lipidology. 11(6). 1448–1457. 48 indexed citations

3.

Tóth, Peter P., Mark D. Danese, Guillermo Villa, et al.. (2017). Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context. Journal of Medical Economics. 20(6). 555–564. 48 indexed citations

4.

Raal, Frederick J., Robert P. Giugliano, Marc S. Sabatine, et al.. (2016). PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role. Journal of Lipid Research. 57(6). 1086–1096. 169 indexed citations

5.

Weisel, Richard D., Nancy A. Nussmeier, Mark F. Newman, et al.. (2014). Predictors of contemporary coronary artery bypass grafting outcomes. Journal of Thoracic and Cardiovascular Surgery. 148(6). 2720–2726.e2. 21 indexed citations

6.

Newman, Mark F., T. Bruce Ferguson, Jennifer A. White, et al.. (2013). Effect of Adenosine-Regulating Agent Acadesine on Morbidity and Mortality Associated With Coronary Artery Bypass Grafting. Survey of Anesthesiology. 57(2). 59–59. 3 indexed citations

7.

Newman, Mark F., T. Bruce Ferguson, Jennifer A. White, et al.. (2012). Effect of Adenosine-Regulating Agent Acadesine on Morbidity and Mortality Associated With Coronary Artery Bypass Grafting. JAMA. 308(2). 157–64. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact